{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:15:51Z","timestamp":1792077351994,"version":"4.4.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,15]]},"DOI":"10.1093\/hmg\/ddr424","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T20:35:13Z","timestamp":1316205313000},"page":"4851-4864","source":"Crossref","is-referenced-by-count":120,"title":["Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification"],"prefix":"10.1093","volume":"20","author":[{"given":"Hsiang-Po","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Hsun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Liang","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Tzu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chuan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Nerng","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chih","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,9,15]]},"reference":[{"key":"key\n\t\t\t\t20170522153701_DDR424C1","first-page":"304","article-title":"Concerning idiopathic hypertrophy of the heart [in Dutch]","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"key\n\t\t\t\t20170522153701_DDR424C2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"alpha-Glucosidase deficiency in generalized glycogen storage disease (Pompe's disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170522153701_DDR424C3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1172\/JCI109247","article-title":"Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts","volume":"62","author":"Beratis","year":"1978","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170522153701_DDR424C4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/brain\/91.3.435","article-title":"Adult myopathy from glycogen storage disease due to acid maltase deficiency","volume":"91","author":"Hudgson","year":"1968","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170522153701_DDR424C5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1357-4310(00)01694-4","article-title":"Towards a molecular therapy for glycogen storage disease type II (Pompe disease)","volume":"6","author":"Chen","year":"2000","journal-title":"Mol. Med. Today"},{"key":"key\n\t\t\t\t20170522153701_DDR424C6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170522153701_DDR424C7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Invest."},{"key":"key\n\t\t\t\t20170522153701_DDR424C8","first-page":"123","article-title":"Pathology of skeletal muscle cells in adult-onset glycogenosis type II (Pompe disease): ultrastructural study","volume":"46","author":"Lewandowska","year":"2008","journal-title":"Folia Neuropathol."},{"key":"key\n\t\t\t\t20170522153701_DDR424C9","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"key\n\t\t\t\t20170522153701_DDR424C10","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170522153701_DDR424C11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","article-title":"Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial","volume":"15","author":"Klinge","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"key\n\t\t\t\t20170522153701_DDR424C12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522153701_DDR424C13","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170522153701_DDR424C14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr. Res."},{"key":"key\n\t\t\t\t20170522153701_DDR424C15","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522153701_DDR424C16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nmd.2010.07.277","article-title":"Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study","volume":"20","author":"van Capelle","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"key\n\t\t\t\t20170522153701_DDR424C17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522153701_DDR424C18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/522236","article-title":"Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance","volume":"81","author":"Sun","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522153701_DDR424C19","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522153701_DDR424C20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ymgme.2008.12.012","article-title":"Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches","volume":"96","author":"Takikita","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522153701_DDR424C21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522153701_DDR424C22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature05944","article-title":"In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state","volume":"448","author":"Wernig","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522153701_DDR424C23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522153701_DDR424C24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522153701_DDR424C25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522153701_DDR424C26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522153701_DDR424C27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522153701_DDR424C28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","article-title":"Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors","volume":"136","author":"Soldner","year":"2009","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522153701_DDR424C29","doi-asserted-by":"crossref","first-page":"15768","DOI":"10.1073\/pnas.0906894106","article-title":"Generation of pluripotent stem cells from patients with type 1 diabetes","volume":"106","author":"Maehr","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522153701_DDR424C30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature08320","article-title":"Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs","volume":"461","author":"Lee","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522153701_DDR424C31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature08792","article-title":"Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients","volume":"464","author":"Agarwal","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522153701_DDR424C32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.stem.2010.04.005","article-title":"Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells","volume":"6","author":"Urbach","year":"2010","journal-title":"Cell Stem Cell"},{"key":"key\n\t\t\t\t20170522153701_DDR424C33","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature09005","article-title":"Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome","volume":"465","author":"Carvajal-Vergara","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522153701_DDR424C34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-specific induced pluripotent stem-cell models for long-QT syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522153701_DDR424C35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2010-05-287607","article-title":"Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)","volume":"117","author":"Tolar","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170522153701_DDR424C36","doi-asserted-by":"crossref","first-page":"33510","DOI":"10.1074\/jbc.M110.122093","article-title":"Factors from human embryonic stem cell-derived fibroblast-like cells promote topology-dependent hepatic differentiation in primate embryonic and induced pluripotent stem cells","volume":"285","author":"Huang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522153701_DDR424C37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2007.07.009","article-title":"Pompe disease: current state of treatment modalities and animal models","volume":"92","author":"Geel","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522153701_DDR424C38","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.stem.2009.11.009","article-title":"Technical challenges in using human induced pluripotent stem cells to model disease","volume":"5","author":"Saha","year":"2009","journal-title":"Cell Stem Cell"},{"key":"key\n\t\t\t\t20170522153701_DDR424C39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4615-2401-4_7","article-title":"Biogenesis of the lysosomal membrane","volume":"22","author":"Fukuda","year":"1994","journal-title":"Subcell. Biochem."},{"key":"key\n\t\t\t\t20170522153701_DDR424C40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/acprof:oso\/9780198508786.003.0013","article-title":"Enzyme replacement therapy","volume-title":"Lysosomal Disorders of the Brain","author":"Neufeld","year":"2004"},{"key":"key\n\t\t\t\t20170522153701_DDR424C41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mus.880140509","article-title":"Infantile Pompe's disease, lipid storage, and partial carnitine deficiency","volume":"14","author":"Verity","year":"1991","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522153701_DDR424C42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ymgme.2010.08.001","article-title":"Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy","volume":"101","author":"Raben","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522153701_DDR424C43","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cbdv.200790159","article-title":"The N-acylethanolamine-hydrolyzing acid amidase (NAAA)","volume":"4","author":"Tsuboi","year":"2007","journal-title":"Chem. Biodivers."},{"key":"key\n\t\t\t\t20170522153701_DDR424C44","doi-asserted-by":"crossref","first-page":"40091","DOI":"10.1074\/jbc.M404899200","article-title":"A novel dynamin-associating molecule, formin-binding protein 17, induces tubular membrane invaginations and participates in endocytosis","volume":"279","author":"Kamioka","year":"2004","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522153701_DDR424C45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2006.05.034","article-title":"DRAM, a p53-induced modulator of autophagy, is critical for apoptosis","volume":"126","author":"Crighton","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522153701_DDR424C46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18632\/aging.100112","article-title":"CYB5R3: a key player in aerobic metabolism and aging","volume":"2","author":"de Cabo","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"key\n\t\t\t\t20170522153701_DDR424C47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1749-6632.1995.tb26670.x","article-title":"Cytokine signal transduction through a homo- or heterodimer of gp130","volume":"766","author":"Kishimoto","year":"1995","journal-title":"Ann. NY Acad. Sci."},{"key":"key\n\t\t\t\t20170522153701_DDR424C48","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1152\/japplphysiol.00590.2005","article-title":"Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle","volume":"99","author":"Keller","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"key\n\t\t\t\t20170522153701_DDR424C49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-007-0658-z","article-title":"Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis","volume":"102","author":"Fischer","year":"2007","journal-title":"Basic. Res. Cardiol."},{"key":"key\n\t\t\t\t20170522153701_DDR424C50","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1093\/hmg\/ddn053","article-title":"Generation of isogenic pluripotent stem cells","volume":"17","author":"Byrne","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522153701_DDR424C51","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170522153701_DDR424C52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1203\/00006450-199803000-00011","article-title":"Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts","volume":"43","author":"Yang","year":"1998","journal-title":"Pediatr. Res."},{"key":"key\n\t\t\t\t20170522153701_DDR424C53","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1523\/JNEUROSCI.0924-09.2009","article-title":"Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia","volume":"29","author":"Lee","year":"2009","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522153701_DDR424C54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/20\/24\/4851\/17254384\/ddr424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T03:07:48Z","timestamp":1503457668000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddr424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":54,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2011,9,15]]},"published-print":{"date-parts":[[2011,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddr424","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,15]]}}}